All trials were approved by Independent Ethics Committees and Institutional Review Boards at each participating center and conducted in compliance with the International Conference on Harmonisation Good Clinical Practice guidelines and the Declaration of Helsinki
1 This action, coupled with potential effects on appetite centers in the brain, contributes to increased feelings of fullness and reduced appetite
Weight management is another critical concern
The Verdict: May offer supportive benefits for metabolism and satiety, but not a strong or direct GLP-1 booster
Anesthetics: These are numbing drugs that can block the pain signals from the plantar fascia
Research is needed to help illustrate the size and nature of access gaps so that we can design better coverage policies. The research team plans to continue studying inequities in GLP-1 access, including differences by race, ethnicity, and socioeconomic status.